The University of Florida Health Science Center, also known as the J. Hillis Miller Health Science Center, is the medical division of the University of Florida. Its primary campuses are located on the university's main campus in Gainesville, Florida and at UF Health at Jacksonville in Jacksonville, Florida.

During the past decade, University of Florida Health Science Center - Jacksonville conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 17 clinical trials were completed, i.e. on average, 154.5% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 5 clinical trials were completed. i.e. 500% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Florida Health Science Center - Jacksonville" #1 sponsor was "National Cancer Institute (NCI)" with 6 trials, followed by "Radiation Therapy Oncology Group" with 5 trials sponsored, "Sanofi" with 4 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored and "Lisata Therapeutics, Inc." with 2 trials sponsored. Other sponsors include 26 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Florida Health Science Center - Jacksonville" #1 collaborator was "National Cancer Institute (NCI)" with 10 trials as a collaborator, "NRG Oncology" with 7 trials as a collaborator, "Radiation Therapy Oncology Group" with 6 trials as a collaborator, "University of Alabama at Birmingham" with 3 trials as a collaborator and "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 2 trials as a collaborator. Other collaborators include 43 different institutions and companies that were collaborators in the rest 50 trials.

According to Clinical.Site data, the most researched conditions in "University of Florida Health Science Center - Jacksonville" are "Adult Giant Cell Glioblastoma" (3 trials), "Adult Glioblastoma" (3 trials), "Adult Gliosarcoma" (3 trials), "Colorectal Cancer" (3 trials) and "Herpes Simplex" (2 trials). Many other conditions were trialed in "University of Florida Health Science Center - Jacksonville" in a lesser frequency.

Most popular intervention types in "University of Florida Health Science Center - Jacksonville" are "Drug" (35 trials), "Biological" (11 trials), "Radiation" (11 trials), "Other" (9 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Cisplatin" (3 trials), "Paclitaxel" (3 trials), "intensity-modulated radiation therapy" (3 trials) and "3-dimensional conformal radiation therapy" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of Florida Health Science Center - Jacksonville" are 39 trials for "All" genders, 9 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "University of Florida Health Science Center - Jacksonville". undefined are not yet recruiting, 5 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 33 completed trials in University of Florida Health Science Center - Jacksonville, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in University of Florida Health Science Center - Jacksonville, 3 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".